These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prostaglandins. 2: Effect on several organ systems and clinical significance]. Greven J Med Klin; 1979 Apr; 74(16):597-601. PubMed ID: 379561 [No Abstract] [Full Text] [Related]
3. Prostaglandins and the ductus arteriosus. Lancet; 1976 Oct; 2(7990):837. PubMed ID: 61506 [No Abstract] [Full Text] [Related]
4. Clinical applications of prostaglandins and their inhibitors. Moskowitz MA; Coughlin SR Stroke; 1981; 12(6):882-6. PubMed ID: 7029794 [No Abstract] [Full Text] [Related]
5. [Prostaglandins in the newborn infant]. Kääpä P Duodecim; 1984; 100(16):1072-7. PubMed ID: 6510262 [No Abstract] [Full Text] [Related]
6. [The role of prostaglandins in the pathogenesis of Bartter's syndrome]. Radó J; Simatupang T; Boer P; Mees EJ Orv Hetil; 1981 Jun; 122(25):1519-27. PubMed ID: 7312332 [No Abstract] [Full Text] [Related]
7. New uses for acetylsalicylic acid and other prostaglandin antagonists. Cooperman EM Can Med Assoc J; 1977 Aug; 117(4):309, 312. PubMed ID: 890626 [No Abstract] [Full Text] [Related]
8. Aspirin: new uses for an old drug. Horwitz DL Compr Ther; 1979 Oct; 5(10):3-4. PubMed ID: 498743 [No Abstract] [Full Text] [Related]
9. Cardiovascular pharmacological therapy in children--a review. Part 4: Manipulation of vascular resistance and patent ductus arteriosus. Chan KY; Yip WC; Tay JS J Singapore Paediatr Soc; 1989; 31(1-2):26-31. PubMed ID: 2671493 [No Abstract] [Full Text] [Related]
10. Risk factors for persistent ductus arteriosus patency during indomethacin treatment. Chorne N; Jegatheesan P; Lin E; Shi R; Clyman RI J Pediatr; 2007 Dec; 151(6):629-34. PubMed ID: 18035143 [TBL] [Abstract][Full Text] [Related]
11. [Derivatives of arachidonic acid. II. Medical perspectives]. Anker R; Quezada A Bol Med Hosp Infant Mex; 1986 May; 43(5):316-22. PubMed ID: 3524602 [No Abstract] [Full Text] [Related]
13. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies]. Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760 [No Abstract] [Full Text] [Related]
14. Effects of prostaglandins and inhibitors of prostaglandin synthesis in the fetus and newborn infant. Rudolph AM; Heymann MA J Perinat Med; 1981; 9 Suppl 1():91-2. PubMed ID: 7229898 [No Abstract] [Full Text] [Related]
15. Mass spectrometric determination of urinary prostaglandins in preterm infants. The basis for an effective and safe therapeutic regimen for the pharmacological closure. Seyberth HW; Müller H; Erlenmaier T; Mrongovius R Eur J Clin Pharmacol; 1980 Jul; 18(1):89-93. PubMed ID: 7398753 [No Abstract] [Full Text] [Related]
16. [Prostaglandins and inhibitors of their synthesis in occlusive vascular diseases]. Viinikka L Duodecim; 1984; 100(16):1007-16. PubMed ID: 6510257 [No Abstract] [Full Text] [Related]
17. The clinical significance of arachidonic acid metabolites. Oelz O Ergeb Inn Med Kinderheilkd; 1982; 50():105-44. PubMed ID: 6763565 [No Abstract] [Full Text] [Related]